US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nexalin Technology, Inc.

0.5169

+0.00200.39%

Post-market: 0.54000.0231+4.47%19:58 EST

Volume:262.66K

Turnover:136.56K

Market Cap:9.64M

PE:-0.86

High:0.5400

Open:0.5194

Low:0.5001

Close:0.5149

52wk High:3.80

52wk Low:0.5000

Shares:18.65M

Float Shares:15.47M

Volume Ratio:0.17

T/O Rate:1.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5992

EPS(LYR):-0.8255

ROE:-178.46%

ROA:-106.58%

PB:2.02

PE(LYR):-0.63

Loading ...

Overview Company News Filings

Nexalin Technology Partners with UC San Diego to Launch AI-Driven NeuroCare Virtual Clinic

Nexalin Technology highlights research validating neurostimulation technology

RBC Capital Reaffirms Their Hold Rating on Nuix Ltd. (NXL)

BRIEF-Nexalin Technology Receives Nasdaq Listing Status Notification

Nexalin Technology Neurostimulation Device Shows Significant ADHD Symptom Improvement in Clinical Study

Nexalin Advances Non-Invasive Alzheimer's Therapy Toward FDA Clinical Trials

BRIEF-Nexalin Technology Completes FDA Q-Submission Meeting For Gen-2 Sync

Nexalin Technology Inc - Potential De Novo Pathway Discussed for Nexalin's Technology

THOMSON REUTERS

Nexalin Technology Inc - Reviewed Endpoints for Alzheimer's Outcomes Including Cognitive Assessments

THOMSON REUTERS

Nexalin Technology Inc - Plans U.S. Pilot and Pivotal Studies for Gen-2 Sync

THOMSON REUTERS

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 Sync™ Neurostimulation Console in Alzheimer’s Disease Program

THOMSON REUTERS

Nexalin Technology Inc: Intends to Incorporate FDA's Feedback From Q-Sub Meeting Into Its Final Pilot Study Protocol

THOMSON REUTERS

Nexalin Technology Hosts Live Investor Webinar Showcasing Mental Health Innovations

Nuix (ASX:NXL) delivers shareholders solid 39% CAGR over 3 years, surging 12% in the last week alone

Simply Wall St.

Morgan Stanley Sticks to Their Buy Rating for Nuix Ltd. (NXL)

Nexalin 15 mA Neurostimulation Device Shows Promise in Treating Gambling and Alcohol Use Disorders

Nexalin Technology Faces Financial Risks Amid U.S.-China Trade Tensions

Nexalin Technology Secures Exclusive Distribution Agreement With Carmi Masha in Israel

Nuix Limited (ASX:NXL) May Have Run Too Fast Too Soon With Recent 33% Price Plummet

Simply Wall St.

BRIEF-Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by US FDA for the Treatment of Alzheimer’s Disease and Dementia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NXL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","market":"US","secType":"STK","nameCN":"Nexalin Technology, Inc.","latestPrice":0.5169,"timestamp":1770670800000,"preClose":0.5149,"halted":0,"volume":262661,"hourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5169,"latestTime":"19:58 EST","volume":4012,"amount":2097.6743,"timestamp":1770685084841,"change":0.0231,"changeRate":0.044689,"amplitude":0.06036},"delay":0,"changeRate":0.003884249368809481,"floatShares":15469100,"shares":18651939,"eps":-0.599183,"marketStatus":"Closed","change":0.002,"latestTime":"02-09 16:00:00 EST","open":0.5194,"high":0.54,"low":0.5001,"amount":136563.22193556,"amplitude":0.077491,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.599183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"listingDate":1663300800000,"exchange":"NASDAQ","adjPreClose":0.5149,"preHourTrading":{"tag":"盘前","latestPrice":0.5297,"preClose":0.5149,"latestTime":"09:25 EST","volume":1353,"amount":718.8263049,"timestamp":1770647140289,"change":0.0148,"changeRate":0.028743,"amplitude":0.05807},"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5169,"latestTime":"19:58 EST","volume":4012,"amount":2097.6743,"timestamp":1770685084841,"change":0.0231,"changeRate":0.044689,"amplitude":0.06036},"volumeRatio":0.172299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","floatShares":15469100,"roa":"-106.58%","roe":"-178.46%","lyrEps":-0.825452,"volumeRatio":0.172299,"shares":18651939,"dividePrice":0,"high":0.54,"amplitude":0.077491,"preClose":0.5149,"low":0.5001,"week52Low":0.5,"pbRate":"2.02","psRate":"61.44","week52High":3.8,"institutionHeld":0,"latestPrice":0.5169,"eps":-0.599183,"divideRate":0,"volume":262661,"delay":0,"ttmEps":-0.599183,"open":0.5194,"prevYearClose":0.558,"prevWeekClose":0.5149,"prevMonthClose":0.57,"prevQuarterClose":0.558,"fiveDayClose":0.5733,"twentyDayClose":0.7124,"sixtyDayClose":1.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"NXL","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"","actualEps":-0.13},{"market":"US","date":"2025-08-06","symbol":"NXL","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742792400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXL","date":"2026-02-06","current":-0.862675,"percent":0.800236,"low":-11.123806,"twenty":-4.309279,"median":-2.525592,"eighty":-1.333146,"high":-0.46259,"avg":-3.089951,"sd":2.266588,"marketCap":11564202},"quantilePoints":[{"date":"2022-09-16","current":-5.073734,"twenty":-6.382342,"median":-6.382342,"eighty":-5.597177,"marketCap":16379912},{"date":"2022-09-23","current":-2.773641,"twenty":-5.858899,"median":-3.709464,"eighty":-3.008161,"marketCap":8954352},{"date":"2022-09-30","current":-2.435392,"twenty":-4.568616,"median":-2.908941,"eighty":-2.579712,"marketCap":7862357},{"date":"2022-10-07","current":-2.503042,"twenty":-3.729758,"median":-2.593242,"eighty":-2.489512,"marketCap":8080756},{"date":"2022-10-14","current":-2.886391,"twenty":-3.427589,"median":-2.773641,"eighty":-2.503042,"marketCap":9318350},{"date":"2022-10-21","current":-3.044241,"twenty":-3.11189,"median":-2.852566,"eighty":-2.512062,"marketCap":9827947},{"date":"2022-10-28","current":-3.333782,"twenty":-3.13895,"median":-2.908715,"eighty":-2.525592,"marketCap":10762694},{"date":"2022-11-04","current":-3.630539,"twenty":-3.342712,"median":-2.948628,"eighty":-2.543632,"marketCap":11720737},{"date":"2022-11-11","current":-8.471203,"twenty":-3.677893,"median":-2.954041,"eighty":-2.579712,"marketCap":13249529},{"date":"2022-11-18","current":-8.378112,"twenty":-4.631756,"median":-3.015602,"eighty":-2.593242,"marketCap":13103929},{"date":"2022-11-25","current":-10.658821,"twenty":-7.755915,"median":-3.13444,"eighty":-2.629322,"marketCap":16671110},{"date":"2022-12-02","current":-10.938092,"twenty":-8.471203,"median":-3.31484,"eighty":-2.782661,"marketCap":17107908},{"date":"2022-12-09","current":-10.333006,"twenty":-9.802392,"median":-3.467052,"eighty":-2.818741,"marketCap":16161513},{"date":"2022-12-16","current":-3.444335,"twenty":-9.802392,"median":-3.607989,"eighty":-2.818741,"marketCap":5387171},{"date":"2022-12-23","current":-3.63517,"twenty":-9.44865,"median":-3.619264,"eighty":-2.832271,"marketCap":5685649},{"date":"2022-12-30","current":-3.486225,"twenty":-9.076288,"median":-3.596714,"eighty":-2.886391,"marketCap":5452690},{"date":"2023-01-06","current":-3.504843,"twenty":-8.852872,"median":-3.596714,"eighty":-2.90425,"marketCap":5481810},{"date":"2023-01-13","current":-4.326829,"twenty":-8.648074,"median":-3.630539,"eighty":-2.908896,"marketCap":6767451},{"date":"2023-01-20","current":-5.301949,"twenty":-8.527057,"median":-3.653322,"eighty":-2.929642,"marketCap":8292603},{"date":"2023-01-27","current":-5.205601,"twenty":-8.471203,"median":-3.704665,"eighty":-2.949666,"marketCap":8141908},{"date":"2023-02-03","current":-5.026867,"twenty":-8.415348,"median":-3.810938,"eighty":-2.953951,"marketCap":7862357},{"date":"2023-02-10","current":-5.678498,"twenty":-8.378112,"median":-3.923688,"eighty":-2.954041,"marketCap":8881552},{"date":"2023-02-17","current":-5.119958,"twenty":-8.21083,"median":-4.305419,"eighty":-2.967571,"marketCap":8007957},{"date":"2023-02-24","current":-4.087122,"twenty":-7.763997,"median":-4.305419,"eighty":-2.98074,"marketCap":6392533},{"date":"2023-03-03","current":-4.468326,"twenty":-6.909555,"median":-4.267252,"eighty":-3.009875,"marketCap":6988762},{"date":"2023-03-10","current":-4.747597,"twenty":-6.382342,"median":-4.328691,"eighty":-3.071301,"marketCap":7425560},{"date":"2023-03-17","current":-5.026867,"twenty":-6.100804,"median":-4.480661,"eighty":-3.12993,"marketCap":7862357},{"date":"2023-03-24","current":-4.794607,"twenty":-5.641262,"median":-4.519061,"eighty":-3.175481,"marketCap":7499087},{"date":"2023-03-31","current":-3.433381,"twenty":-5.576099,"median":-4.480661,"eighty":-3.247866,"marketCap":5829249},{"date":"2023-04-06","current":-3.31965,"twenty":-5.510936,"median":-4.366393,"eighty":-3.315802,"marketCap":5636155},{"date":"2023-04-14","current":-3.60505,"twenty":-5.306138,"median":-4.305419,"eighty":-3.315802,"marketCap":6120712},{"date":"2023-04-21","current":-3.347546,"twenty":-5.306138,"median":-4.128082,"eighty":-3.315802,"marketCap":5683518},{"date":"2023-04-28","current":-3.562562,"twenty":-5.306138,"median":-4.003341,"eighty":-3.322476,"marketCap":6048575},{"date":"2023-05-05","current":-3.733802,"twenty":-5.3053,"median":-3.915598,"eighty":-3.335677,"marketCap":6339308},{"date":"2023-05-12","current":-3.01616,"twenty":-5.282679,"median":-3.810938,"eighty":-3.335677,"marketCap":6192120},{"date":"2023-05-19","current":-2.818112,"twenty":-5.188472,"median":-3.732836,"eighty":-3.214916,"marketCap":5785530},{"date":"2023-05-26","current":-2.767002,"twenty":-5.119958,"median":-3.715347,"eighty":-3.089151,"marketCap":5680603},{"date":"2023-06-02","current":-3.273482,"twenty":-5.119958,"median":-3.699867,"eighty":-3.044241,"marketCap":6720396},{"date":"2023-06-09","current":-3.251121,"twenty":-5.119958,"median":-3.681736,"eighty":-3.052363,"marketCap":6674490},{"date":"2023-06-16","current":-3.263544,"twenty":-5.073734,"median":-3.647538,"eighty":-3.044241,"marketCap":6699993},{"date":"2023-06-23","current":-3.023969,"twenty":-5.073476,"median":-3.630539,"eighty":-3.042316,"marketCap":6208150},{"date":"2023-06-30","current":-3.229471,"twenty":-5.073412,"median":-3.607989,"eighty":-3.049114,"marketCap":6630042},{"date":"2023-07-07","current":-3.28271,"twenty":-5.073412,"median":-3.60505,"eighty":-3.06656,"marketCap":6739341},{"date":"2023-07-14","current":-2.838342,"twenty":-5.054794,"median":-3.60505,"eighty":-3.038466,"marketCap":5827063},{"date":"2023-07-21","current":-2.875965,"twenty":-5.026867,"median":-3.603763,"eighty":-3.000615,"marketCap":5904301},{"date":"2023-07-28","current":-2.789363,"twenty":-5.008249,"median":-3.588807,"eighty":-2.957877,"marketCap":5726509},{"date":"2023-08-04","current":-2.594508,"twenty":-4.961704,"median":-3.5728,"eighty":-2.942778,"marketCap":5326476},{"date":"2023-08-11","current":-2.284658,"twenty":-4.933777,"median":-3.560201,"eighty":-2.908805,"marketCap":4690359},{"date":"2023-08-18","current":-1.816454,"twenty":-4.933777,"median":-3.537425,"eighty":-2.875326,"marketCap":4424754},{"date":"2023-08-25","current":-1.282203,"twenty":-4.933777,"median":-3.497652,"eighty":-2.827127,"marketCap":3123356},{"date":"2023-09-01","current":-1.360051,"twenty":-4.915159,"median":-3.486225,"eighty":-2.818364,"marketCap":3312988},{"date":"2023-09-08","current":-1.283424,"twenty":-4.887232,"median":-3.444801,"eighty":-2.803631,"marketCap":3126330},{"date":"2023-09-15","current":-1.312732,"twenty":-4.887232,"median":-3.433381,"eighty":-2.788795,"marketCap":3197721},{"date":"2023-09-22","current":-1.312732,"twenty":-4.887139,"median":-3.39261,"eighty":-2.768493,"marketCap":3197721},{"date":"2023-09-29","current":-1.472702,"twenty":-4.877551,"median":-3.360231,"eighty":-2.700987,"marketCap":3587397},{"date":"2023-10-06","current":-1.190617,"twenty":-4.840687,"median":-3.343255,"eighty":-2.636674,"marketCap":2900259},{"date":"2023-10-13","current":-1.330438,"twenty":-4.831471,"median":-3.336304,"eighty":-2.575202,"marketCap":3240853},{"date":"2023-10-20","current":-1.010498,"twenty":-4.785205,"median":-3.31965,"eighty":-2.503042,"marketCap":2461502},{"date":"2023-10-27","current":-1.037974,"twenty":-4.766401,"median":-3.31484,"eighty":-2.480492,"marketCap":2528431},{"date":"2023-11-03","current":-0.924102,"twenty":-4.747597,"median":-3.278273,"eighty":-2.375098,"marketCap":2251047},{"date":"2023-11-10","current":-1.098726,"twenty":-4.736426,"median":-3.263544,"eighty":-1.867376,"marketCap":2676418},{"date":"2023-11-17","current":-0.465824,"twenty":-4.684017,"median":-3.249346,"eighty":-1.703376,"marketCap":2141729},{"date":"2023-11-24","current":-0.526479,"twenty":-4.652366,"median":-3.216344,"eighty":-1.47551,"marketCap":2420600},{"date":"2023-12-01","current":-0.630966,"twenty":-4.633097,"median":-3.194333,"eighty":-1.433259,"marketCap":2901002},{"date":"2023-12-08","current":-0.64714,"twenty":-4.607776,"median":-3.192381,"eighty":-1.383558,"marketCap":2975368},{"date":"2023-12-15","current":-0.622393,"twenty":-4.601166,"median":-3.165229,"eighty":-1.337643,"marketCap":2861589},{"date":"2023-12-22","current":-0.483617,"twenty":-4.588878,"median":-3.140169,"eighty":-1.312732,"marketCap":2223532},{"date":"2023-12-29","current":-0.650213,"twenty":-4.584689,"median":-3.123348,"eighty":-1.283424,"marketCap":2989497},{"date":"2024-01-05","current":-0.630804,"twenty":-4.5602,"median":-3.103112,"eighty":-1.276097,"marketCap":2900259},{"date":"2024-01-12","current":-0.750495,"twenty":-4.528986,"median":-3.052363,"eighty":-1.223467,"marketCap":3450564},{"date":"2024-01-19","current":-0.727851,"twenty":-4.517385,"median":-3.034616,"eighty":-1.19715,"marketCap":3346452},{"date":"2024-01-26","current":-0.528905,"twenty":-4.506122,"median":-3.016515,"eighty":-1.180419,"marketCap":2431755},{"date":"2024-02-02","current":-0.627407,"twenty":-4.483128,"median":-2.986964,"eighty":-1.132613,"marketCap":2884642},{"date":"2024-02-09","current":-0.490248,"twenty":-4.442634,"median":-2.958836,"eighty":-1.026617,"marketCap":2254021},{"date":"2024-02-16","current":-0.514672,"twenty":-4.373933,"median":-2.953815,"eighty":-0.975085,"marketCap":2366314},{"date":"2024-02-23","current":-0.501408,"twenty":-4.328319,"median":-2.942336,"eighty":-0.95921,"marketCap":2305334},{"date":"2024-03-01","current":-0.501733,"twenty":-4.322547,"median":-2.909667,"eighty":-0.893084,"marketCap":2306828},{"date":"2024-03-08","current":-0.881508,"twenty":-4.290152,"median":-2.892646,"eighty":-0.76764,"marketCap":4052926},{"date":"2024-03-15","current":-0.873421,"twenty":-4.211677,"median":-2.875432,"eighty":-0.727851,"marketCap":4015743},{"date":"2024-03-22","current":-0.721381,"twenty":-4.136461,"median":-2.838342,"eighty":-0.725133,"marketCap":3316706},{"date":"2024-03-28","current":-1.261608,"twenty":-4.114119,"median":-2.824855,"eighty":-0.727851,"marketCap":5800518},{"date":"2024-04-05","current":-3.439365,"twenty":-4.114119,"median":-2.834438,"eighty":-0.727851,"marketCap":15988608},{"date":"2024-04-12","current":-3.935274,"twenty":-4.087122,"median":-2.8749,"eighty":-0.727851,"marketCap":18293942},{"date":"2024-04-19","current":-2.351566,"twenty":-4.003341,"median":-2.866559,"eighty":-0.748716,"marketCap":10931746},{"date":"2024-04-26","current":-2.215591,"twenty":-3.983265,"median":-2.830534,"eighty":-0.750495,"marketCap":10299638},{"date":"2024-05-03","current":-2.639513,"twenty":-3.968788,"median":-2.818741,"eighty":-0.761817,"marketCap":12270327},{"date":"2024-05-10","current":-1.855657,"twenty":-3.967268,"median":-2.818112,"eighty":-0.782844,"marketCap":8626411},{"date":"2024-05-17","current":-2.001563,"twenty":-3.952607,"median":-2.803737,"eighty":-0.792549,"marketCap":9890627},{"date":"2024-05-24","current":-1.595231,"twenty":-3.935274,"median":-2.80356,"eighty":-0.808723,"marketCap":7882755},{"date":"2024-05-31","current":-1.053454,"twenty":-3.909679,"median":-2.788653,"eighty":-0.830719,"marketCap":5205593},{"date":"2024-06-07","current":-1.083553,"twenty":-3.883526,"median":-2.768954,"eighty":-0.840101,"marketCap":5354324},{"date":"2024-06-14","current":-1.353237,"twenty":-3.84715,"median":-2.767002,"eighty":-0.866951,"marketCap":6686956},{"date":"2024-06-21","current":-2.468093,"twenty":-3.825734,"median":-2.715187,"eighty":-0.878273,"marketCap":12195961},{"date":"2024-06-28","current":-2.543339,"twenty":-3.85501,"median":-2.750143,"eighty":-0.883801,"marketCap":12567789},{"date":"2024-07-05","current":-2.763695,"twenty":-3.830253,"median":-2.748489,"eighty":-0.900328,"marketCap":13656664},{"date":"2024-07-12","current":-3.042207,"twenty":-3.814393,"median":-2.768422,"eighty":-0.923336,"marketCap":15032918},{"date":"2024-07-19","current":-2.656575,"twenty":-3.788667,"median":-2.7686,"eighty":-0.92459,"marketCap":13127336},{"date":"2024-07-26","current":-2.656575,"twenty":-3.746677,"median":-2.767002,"eighty":-0.925468,"marketCap":13127336},{"date":"2024-08-02","current":-2.335215,"twenty":-3.733029,"median":-2.724235,"eighty":-0.933966,"marketCap":11539352},{"date":"2024-08-09","current":-1.857517,"twenty":-3.730047,"median":-2.697437,"eighty":-0.951517,"marketCap":10037108},{"date":"2024-08-16","current":-1.912181,"twenty":-3.726016,"median":-2.669971,"eighty":-0.95921,"marketCap":10332484},{"date":"2024-08-23","current":-1.887789,"twenty":-3.720581,"median":-2.656575,"eighty":-0.962629,"marketCap":10200681},{"date":"2024-08-30","current":-1.804816,"twenty":-3.712993,"median":-2.640081,"eighty":-0.9702,"marketCap":9752340},{"date":"2024-09-06","current":-1.620652,"twenty":-3.707544,"median":-2.621599,"eighty":-0.974474,"marketCap":8757204},{"date":"2024-09-13","current":-1.313449,"twenty":-3.697985,"median":-2.594508,"eighty":-0.979786,"marketCap":7097231},{"date":"2024-09-20","current":-1.360078,"twenty":-3.690112,"median":-2.581967,"eighty":-0.991663,"marketCap":7349191},{"date":"2024-09-27","current":-1.383196,"twenty":-3.685938,"median":-2.548581,"eighty":-0.995169,"marketCap":7474112},{"date":"2024-10-04","current":-1.288959,"twenty":-3.672451,"median":-2.526811,"eighty":-1.004353,"marketCap":6964899},{"date":"2024-10-11","current":-1.530136,"twenty":-3.661324,"median":-2.506607,"eighty":-1.011474,"marketCap":8268104},{"date":"2024-10-18","current":-2.468594,"twenty":-3.652165,"median":-2.503042,"eighty":-1.016112,"marketCap":13339068},{"date":"2024-10-25","current":-4.486572,"twenty":-3.661324,"median":-2.525592,"eighty":-1.021413,"marketCap":24243226},{"date":"2024-11-01","current":-6.191077,"twenty":-3.697985,"median":-2.535685,"eighty":-1.032299,"marketCap":33453535},{"date":"2024-11-08","current":-8.798889,"twenty":-3.726664,"median":-2.549455,"eighty":-1.04107,"marketCap":48874099},{"date":"2024-11-15","current":-9.771398,"twenty":-3.799802,"median":-2.589694,"eighty":-1.056464,"marketCap":54275973},{"date":"2024-11-22","current":-8.845199,"twenty":-3.898342,"median":-2.594508,"eighty":-1.071514,"marketCap":49131331},{"date":"2024-11-29","current":-9.678778,"twenty":-3.967268,"median":-2.607519,"eighty":-1.083553,"marketCap":53761508},{"date":"2024-12-06","current":-10.095568,"twenty":-4.087122,"median":-2.640081,"eighty":-1.083553,"marketCap":56076597},{"date":"2024-12-13","current":-9.169369,"twenty":-4.212284,"median":-2.656575,"eighty":-1.090175,"marketCap":50931955},{"date":"2024-12-20","current":-6.089758,"twenty":-4.326829,"median":-2.668127,"eighty":-1.098726,"marketCap":33826021},{"date":"2024-12-27","current":-6.830717,"twenty":-4.457081,"median":-2.687275,"eighty":-1.111182,"marketCap":37941734},{"date":"2025-01-03","current":-7.085421,"twenty":-4.489142,"median":-2.700469,"eighty":-1.114296,"marketCap":39356511},{"date":"2025-01-10","current":-6.159222,"twenty":-4.533949,"median":-2.724235,"eighty":-1.116687,"marketCap":34211869},{"date":"2025-01-17","current":-7.316971,"twenty":-4.601166,"median":-2.767002,"eighty":-1.126594,"marketCap":40642671},{"date":"2025-01-24","current":-6.298152,"twenty":-4.653204,"median":-2.768777,"eighty":-1.140878,"marketCap":34983565},{"date":"2025-01-31","current":-6.761252,"twenty":-4.785205,"median":-2.781147,"eighty":-1.16021,"marketCap":37555886},{"date":"2025-02-07","current":-8.613649,"twenty":-4.885096,"median":-2.80356,"eighty":-1.162531,"marketCap":47845170},{"date":"2025-02-14","current":-7.664296,"twenty":-4.924468,"median":-2.803737,"eighty":-1.170895,"marketCap":42571912},{"date":"2025-02-21","current":-6.645477,"twenty":-4.933777,"median":-2.812788,"eighty":-1.175045,"marketCap":36912806},{"date":"2025-02-28","current":-6.274997,"twenty":-5.073412,"median":-2.818741,"eighty":-1.18848,"marketCap":34854949},{"date":"2025-03-07","current":-5.510883,"twenty":-5.113516,"median":-2.827694,"eighty":-1.190617,"marketCap":30610619},{"date":"2025-03-14","current":-3.759943,"twenty":-5.113516,"median":-2.858218,"eighty":-1.190617,"marketCap":28602574},{"date":"2025-03-21","current":-4.16217,"twenty":-5.073734,"median":-2.875432,"eighty":-1.191533,"marketCap":31662384},{"date":"2025-03-28","current":-3.340229,"twenty":-5.073412,"median":-2.892239,"eighty":-1.205576,"marketCap":25409728},{"date":"2025-04-04","current":-2.95549,"twenty":-5.073412,"median":-2.904166,"eighty":-1.220583,"marketCap":22482953},{"date":"2025-04-11","current":-3.2353,"twenty":-5.073412,"median":-2.908715,"eighty":-1.221146,"marketCap":24611517},{"date":"2025-04-17","current":-2.952867,"twenty":-5.036176,"median":-2.908941,"eighty":-1.222104,"marketCap":22462998},{"date":"2025-04-25","current":-3.200324,"twenty":-5.026867,"median":-2.926364,"eighty":-1.222365,"marketCap":24345447},{"date":"2025-05-02","current":-3.130372,"twenty":-5.006553,"median":-2.952867,"eighty":-1.223833,"marketCap":23813306},{"date":"2025-05-09","current":-2.863738,"twenty":-4.984552,"median":-2.926364,"eighty":-1.232277,"marketCap":21784974},{"date":"2025-05-16","current":-2.546651,"twenty":-4.943086,"median":-2.908941,"eighty":-1.235987,"marketCap":21784974},{"date":"2025-05-23","current":-2.426337,"twenty":-4.933777,"median":-2.901322,"eighty":-1.244124,"marketCap":20755762},{"date":"2025-05-30","current":-2.389627,"twenty":-4.933777,"median":-2.892443,"eighty":-1.246052,"marketCap":20441735},{"date":"2025-06-06","current":-2.389627,"twenty":-4.933777,"median":-2.885538,"eighty":-1.247409,"marketCap":20441735},{"date":"2025-06-13","current":-2.439829,"twenty":-4.90585,"median":-2.872857,"eighty":-1.25629,"marketCap":20871183},{"date":"2025-06-20","current":-2.280483,"twenty":-4.887232,"median":-2.860978,"eighty":-1.26374,"marketCap":19508080},{"date":"2025-06-27","current":-2.036146,"twenty":-4.887232,"median":-2.838342,"eighty":-1.27175,"marketCap":17417929},{"date":"2025-07-03","current":-1.954904,"twenty":-4.887139,"median":-2.830534,"eighty":-1.279614,"marketCap":16722953},{"date":"2025-07-11","current":-2.028001,"twenty":-4.885096,"median":-2.818741,"eighty":-1.282203,"marketCap":17348257},{"date":"2025-07-18","current":-2.341568,"twenty":-4.870867,"median":-2.818639,"eighty":-1.282447,"marketCap":20030618},{"date":"2025-07-25","current":-2.423014,"twenty":-4.840687,"median":-2.812788,"eighty":-1.284531,"marketCap":20727335},{"date":"2025-08-01","current":-2.036146,"twenty":-4.831471,"median":-2.80356,"eighty":-1.289684,"marketCap":17417929},{"date":"2025-08-08","current":-1.834314,"twenty":-4.794301,"median":-2.796461,"eighty":-1.292838,"marketCap":16235251},{"date":"2025-08-15","current":-1.584583,"twenty":-4.783983,"median":-2.773641,"eighty":-1.294523,"marketCap":14024916},{"date":"2025-08-22","current":-1.436594,"twenty":-4.747597,"median":-2.7686,"eighty":-1.297226,"marketCap":12715088},{"date":"2025-08-29","current":-1.806173,"twenty":-4.743873,"median":-2.763695,"eighty":-1.300008,"marketCap":15986175},{"date":"2025-09-05","current":-1.672747,"twenty":-4.728979,"median":-2.733284,"eighty":-1.31051,"marketCap":14805239},{"date":"2025-09-12","current":-1.707185,"twenty":-4.654042,"median":-2.700469,"eighty":-1.312732,"marketCap":15110053},{"date":"2025-09-19","current":-1.553686,"twenty":-4.649853,"median":-2.677999,"eighty":-1.312732,"marketCap":13751454},{"date":"2025-09-26","current":-1.885874,"twenty":-4.607962,"median":-2.65926,"eighty":-1.313449,"marketCap":16691601},{"date":"2025-10-03","current":-1.809321,"twenty":-4.607496,"median":-2.656575,"eighty":-1.313449,"marketCap":16014043},{"date":"2025-10-10","current":-2.951906,"twenty":-4.591671,"median":-2.648612,"eighty":-1.322501,"marketCap":26126893},{"date":"2025-10-17","current":-2.617356,"twenty":-4.591153,"median":-2.639513,"eighty":-1.330438,"marketCap":23165845},{"date":"2025-10-24","current":-2.912547,"twenty":-4.584689,"median":-2.656575,"eighty":-1.332257,"marketCap":25778534},{"date":"2025-10-31","current":-3.010944,"twenty":-4.543874,"median":-2.661944,"eighty":-1.335933,"marketCap":26649431},{"date":"2025-11-07","current":-2.459922,"twenty":-4.519061,"median":-2.668127,"eighty":-1.340207,"marketCap":21772411},{"date":"2025-11-14","current":-2.302486,"twenty":-4.515219,"median":-2.656575,"eighty":-1.342955,"marketCap":20378976},{"date":"2025-11-21","current":-2.109997,"twenty":-4.514872,"median":-2.640081,"eighty":-1.353237,"marketCap":18312473},{"date":"2025-11-28","current":-2.32104,"twenty":-4.497371,"median":-2.637036,"eighty":-1.358688,"marketCap":20144094},{"date":"2025-12-05","current":-2.069594,"twenty":-4.487857,"median":-2.617356,"eighty":-1.360073,"marketCap":17961817},{"date":"2025-12-12","current":-2.127405,"twenty":-4.471975,"median":-2.598599,"eighty":-1.369168,"marketCap":18463554},{"date":"2025-12-19","current":-1.730464,"twenty":-4.467249,"median":-2.593242,"eighty":-1.372225,"marketCap":15018541},{"date":"2025-12-26","current":-1.487399,"twenty":-4.459556,"median":-2.590436,"eighty":-1.373126,"marketCap":12909006},{"date":"2026-01-02","current":-1.199204,"twenty":-4.434402,"median":-2.585905,"eighty":-1.360062,"marketCap":10407781},{"date":"2026-01-09","current":-1.530167,"twenty":-4.377277,"median":-2.560483,"eighty":-1.360062,"marketCap":13280180},{"date":"2026-01-16","current":-1.482886,"twenty":-4.333707,"median":-2.548581,"eighty":-1.364623,"marketCap":12869837},{"date":"2026-01-23","current":-1.35394,"twenty":-4.328319,"median":-2.546651,"eighty":-1.355162,"marketCap":11750721},{"date":"2026-01-30","current":-1.224778,"twenty":-4.323512,"median":-2.534416,"eighty":-1.343819,"marketCap":10629740},{"date":"2026-02-06","current":-1.332449,"twenty":-4.309279,"median":-2.525592,"eighty":-1.333146,"marketCap":11564202}],"updateTime":1770675042114},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609530588","title":"Nexalin Technology Partners with UC San Diego to Launch AI-Driven NeuroCare Virtual Clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2609530588","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609530588?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:37","pubTimestamp":1770298629,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. has announced a partnership with the University of California, San Diego  to launch NeuroCare, an AI-driven virtual clinic platform. This collaboration integrates Nexalin's Gen-3 HALO neurostimulation headset with the NeuroCare digital platform, enabling remote, physician-monitored neurotherapy for conditions such as Alzheimer's, mood disorders, traumatic brain injury , and PTSD. The initiative aims to increase patient access, reduce costs, and support long-term care through a subscription-based model, leveraging UCSD's clinical research infrastructure for initial deployment and ongoing clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL4R9L7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","NXL","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","BK4588","LU2210149790.SGD","BK4082","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2608586299","title":"Nexalin Technology highlights research validating neurostimulation technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2608586299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608586299?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:56","pubTimestamp":1770040598,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) highlighted Nexalin’s peer-reviewed clinical research validating its proprietary neurostimulation technology across multip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-highlights-research-validating-neurostimulation-technology-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-highlights-research-validating-neurostimulation-technology-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2607780190","title":"RBC Capital Reaffirms Their Hold Rating on Nuix Ltd. (NXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607780190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607780190?lang=en_us&edition=fundamental","pubTime":"2026-01-31 09:49","pubTimestamp":1769824175,"startTime":"0","endTime":"0","summary":"In a report released on January 29, Garry Sherriff from RBC Capital maintained a Hold rating on Nuix Ltd., with a price target of A$2.15. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-nuix-ltd-nxl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-nuix-ltd-nxl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL"],"gpt_icon":0},{"id":"2605157286","title":"BRIEF-Nexalin Technology Receives Nasdaq Listing Status Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2605157286","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605157286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:34","pubTimestamp":1769207679,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Receives Nasdaq Listing Status NotificationJan 23 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY RECEIVES NASDAQ LISTING STATUS NOTIFICATIONSource text: ID:nGNX4h2gQ0Further company coverage: NXL.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nTUA5SBRC7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2603861142","title":"Nexalin Technology Neurostimulation Device Shows Significant ADHD Symptom Improvement in Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2603861142","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603861142?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:00","pubTimestamp":1768399245,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via GlobeNewswire  on January 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL7wCvQQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","LU2095319765.USD","NXL","BK4585","BK4112","LU2210150020.SGD","BK4588","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4082","LU2210149790.SGD","NDAQ","SG9999014039.USD"],"gpt_icon":0},{"id":"2588460740","title":"Nexalin Advances Non-Invasive Alzheimer's Therapy Toward FDA Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2588460740","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588460740?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:03","pubTimestamp":1764767039,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. has announced progress in its research and development efforts for the treatment of Alzheimer's disease. The company recently held a Q-Sub meeting with the FDA, during which they discussed Nexalin's existing clinical data and plans for new U.S.-based pilot studies, followed by a large pivotal study to assess the safety and efficacy of the Gen-2 SYNC console in patients with mild to moderate Alzheimer's disease. Key aspects such as patient population, dosing paradigm, and statistical analysis were aligned upon, and appropriate clinical endpoints were reviewed. The results of these studies have not yet been presented, as Nexalin is currently incorporating FDA feedback into its final pilot study protocol and will provide updates on clinical milestones as appropriate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL2W8DgN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2588046072","title":"BRIEF-Nexalin Technology Completes FDA Q-Submission Meeting For Gen-2 Sync","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046072","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588046072?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:03","pubTimestamp":1764767023,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Completes FDA Q-Submission Meeting For Gen-2 SyncDec 3 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY COMPLETES FDA Q-SUBMISSION MEETING FOR GEN-2 SYNC NEUROSTIMU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X8103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2588767046","title":"Nexalin Technology Inc - Potential De Novo Pathway Discussed for Nexalin's Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2588767046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588767046?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:01","pubTimestamp":1764766860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90EU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2588504679","title":"Nexalin Technology Inc - Reviewed Endpoints for Alzheimer's Outcomes Including Cognitive Assessments","url":"https://stock-news.laohu8.com/highlight/detail?id=2588504679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588504679?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:01","pubTimestamp":1764766860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90EU:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2588046761","title":"Nexalin Technology Inc - Plans U.S. Pilot and Pivotal Studies for Gen-2 Sync","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588046761?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:01","pubTimestamp":1764766860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90EU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2588046258","title":"Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 Sync™ Neurostimulation Console in Alzheimer’s Disease Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588046258?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:01","pubTimestamp":1764766860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X90EU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2588046796","title":"Nexalin Technology Inc: Intends to Incorporate FDA's Feedback From Q-Sub Meeting Into Its Final Pilot Study Protocol","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588046796?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:00","pubTimestamp":1764766855,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X8103:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2588451053","title":"Nexalin Technology Hosts Live Investor Webinar Showcasing Mental Health Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2588451053","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588451053?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680436,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. will host an exclusive live investor webinar and Q&A session on December 4, 2025, at 4:15 p.m. ET. The event, presented by RedChip Companies, will feature CEO Mark White discussing the company's innovative Deep Intracranial Frequency Stimulation  technology, recent clinical collaborations, and updates on Nexalin's Gen-3 HALO Clarity headset and Virtual Clinic model. The session will also highlight Nexalin's regulatory progress and growth strategy in the mental healthcare market, followed by a live Q&A with investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via GlobeNewswire  on December 02, 2025, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL2CSqVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4082","LU0314104364.USD","LU2210149790.SGD","IE00B64PRP62.GBP","NXL","BK4585","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2587375914","title":"Nuix (ASX:NXL) delivers shareholders solid 39% CAGR over 3 years, surging 12% in the last week alone","url":"https://stock-news.laohu8.com/highlight/detail?id=2587375914","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587375914?lang=en_us&edition=fundamental","pubTime":"2025-11-29 06:45","pubTimestamp":1764369957,"startTime":"0","endTime":"0","summary":"It hasn't been the best quarter for Nuix Limited ( ASX:NXL ) shareholders, since the share price has fallen 26% in that...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-delivers-shareholders-solid-39-cagr-over-3-years","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-delivers-shareholders-solid-39-cagr-over-3-years","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NXL","NXL.AU","BK7016","BK4082"],"gpt_icon":0},{"id":"2584900892","title":"Morgan Stanley Sticks to Their Buy Rating for Nuix Ltd. (NXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584900892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584900892?lang=en_us&edition=fundamental","pubTime":"2025-11-20 13:55","pubTimestamp":1763618138,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew McLeod from Morgan Stanley maintained a Buy rating on Nuix Ltd., with a price target of A$4.35. According to Tip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-nuix-ltd-nxl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-nuix-ltd-nxl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL"],"gpt_icon":0},{"id":"2584538499","title":"Nexalin 15 mA Neurostimulation Device Shows Promise in Treating Gambling and Alcohol Use Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2584538499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584538499?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:00","pubTimestamp":1763474412,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. has announced the publication of an independent, peer-reviewed case report in The American Journal on Addictions evaluating the company's 15 mA neurostimulation device for treating gambling disorder with alcohol use comorbidity. The case was conducted at the Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, using Nexalin's non-invasive device, which delivered a 15 mA current at 77.5 Hz for 40 minutes per session. The study, registered on ClinicalTrials.gov , reported significant clinical improvement and sustained abstinence following treatment. The authors concluded that larger, controlled trials are warranted to further evaluate the device's efficacy in treating addiction comorbidities and other psychiatric disorders. These results have already been published and presented in the peer-reviewed journal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6XzNhx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","LU0314104364.USD","NDAQ","IE00BKPKM429.USD","BK4112","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2583346036","title":"Nexalin Technology Faces Financial Risks Amid U.S.-China Trade Tensions","url":"https://stock-news.laohu8.com/highlight/detail?id=2583346036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583346036?lang=en_us&edition=fundamental","pubTime":"2025-11-15 14:01","pubTimestamp":1763186494,"startTime":"0","endTime":"0","summary":"Nexalin Technology, Inc. (NXL) has disclosed a new risk, in the Regulation category. Nexalin Technology, Inc. faces significant business risks due ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalin-technology-faces-financial-risks-amid-u-s-china-trade-tensions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalin-technology-faces-financial-risks-amid-u-s-china-trade-tensions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2583963905","title":"Nexalin Technology Secures Exclusive Distribution Agreement With Carmi Masha in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2583963905","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583963905?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:15","pubTimestamp":1763043310,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. has announced the appointment of Carmi Masha Technologies Ltd. as the exclusive distributor for its Gen-2 SYNC device in Israel. This follows the recent approval by the Israeli Ministry of Health, allowing commercial sales of the device for the treatment of mental health disorders such as insomnia, depression, and anxiety. Under the agreement, Carmi Masha Technologies will handle sales, marketing, clinical education, importation, registration, and distribution of the SYNC device throughout hospitals, clinics, and private treatment centers in Israel. The companies also plan to explore future applications for the technology in areas including PTSD, traumatic brain injury, and Alzheimer's disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL86SxVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","NDAQ","BK4112","NXL","BK4585","LU2210150020.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2581856870","title":"Nuix Limited (ASX:NXL) May Have Run Too Fast Too Soon With Recent 33% Price Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2581856870","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581856870?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:54","pubTimestamp":1762556083,"startTime":"0","endTime":"0","summary":"Nuix Limited ( ASX:NXL ) shares have had a horrible month, losing 33% after a relatively good period beforehand. For...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-limited-asxnxl-may-have-run-too-fast-too-soon-with-rece","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-limited-asxnxl-may-have-run-too-fast-too-soon-with-rece","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NXL.AU","BK4588","IE00BYQQ9H92.USD","NXL","BK4567","IE00B5TLWC47.USD","BK4082","BK7016","BK4585","BK4104","FAST","IE00BFXG0V08.USD"],"gpt_icon":0},{"id":"2581786777","title":"BRIEF-Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by US FDA for the Treatment of Alzheimer’s Disease and Dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2581786777","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581786777?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:31","pubTimestamp":1762349489,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by US FDA for the Treatment of Alzheimer’s Disease and DementiaNov 5 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY’S Q-SUB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WH1CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}